News

Appendix Removal Early in Life Reduces Risk of Developing Parkinson’s, Study Shows

The healthy human appendix contains Parkinson’s disease-related alpha-synuclein aggregates, and removing the organ early in a person’s life reduces the risk of developing the disease, a study has found. The study, “The vermiform appendix impacts the risk of developing Parkinson’s disease,” was published in Science Translational Medicine. The work was led by researchers at the Center for Neurodegenerative Science at…

Continue Reading

News

Parkinson’s Patients Without Cognitive Impairment Have Normal Life Expectancy, Study Suggests

While patients with some types of parkinsonism have a shorter lifespan, those with Parkinson’s disease without cognitive impairment have a normal life expectancy, a Swedish population-based study suggests. The study, “Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study,” was published in the journal Neurology. Studies have shown that life expectancy for Parkinson’s patients is reduced. However, conflicting data exists…

Continue Reading

News

Other Things Lewy Bodies Might Do to Our Brains

Editor’s note: This column discusses suicide. Pivotal events in my life have piqued my interest in Lewy bodies. The first event was on March 15, 2015, when my life partner, Steve, killed himself. The second was my diagnosis of Parkinson’s disease in November 2015. My fascination with Lewy bodies (I’ll define them in a bit) began in August 2016 when I watched a documentary…

Continue Reading

News

The Grouch and T.O.O.T.S.: Dealing with Irritability

Years ago when I was first diagnosed, my partner asked the neurologist, “Is there something we can do about his irritability?” The doctor responded, “I wish I had a dollar for every time a partner made this request.” It seems this is a prevalent issue. In past columns I have addressed scenario looping breakdowns, exaggerated emotions, deep fatigue, bad days, and ugly…

Continue Reading

News

Benefits of Exercise for Parkinson’s Patients Linked to Increased Dopamine Release, Study Suggests

Engaging in regular exercise can help preserve the motor and non-motor function of Parkinson’s disease patients, most likely as a result of an increased release of dopamine in the brain, a small study suggests. The study, “Habitual Exercisers Versus Sedentary Subjects With Parkinson’s Disease: Multimodal PET and fMRI Study,” was published in the journal Movement Disorders. Exercise has been shown…

Continue Reading

News

Parkinson’s Foundation to Host, Broadcast Summit for Caregivers in English, Spanish

With a focus on self-care and caregiving, the Parkinson’s Foundation is hosting a free bilingual summit for those who attend to the daily needs of Parkinson’s disease (PD) patients. Called Cumbre Para Cuidadores (Summit for Caregivers), the all-day event Dec. 1 at the Sheraton Grand Phoenix in Phoenix, Arizona, will be broadcast online in English and Spanish to satellite locations nationwide.…

Continue Reading

News

Middle-Onset Parkinson’s Linked to Impaired Ability to Detect Emotions, Study Finds

Patients with middle-onset Parkinson’s disease have difficulties recognizing negative and neutral emotions, deficits that appear to be even stronger in female patients, a study shows. The study, “Emotion-Specific Affective Theory of Mind Impairment in Parkinson’s Disease,” was published in the journal Scientific Reports. Parkinson’s disease is known to affect the frontal-subcortical circuit, an area responsible for motor and behavioral processes.…

Continue Reading

News

Phase 2 Trial Testing Anavex 2-73 Recruiting Parkinson’s Patients With Dementia in Spain

The first patient has been enrolled in Anavex Life Sciences‘ Phase 2 clinical trial to evaluate the potential and safety of Anavex 2-73 as a treatment for Parkinson’s disease dementia. Now actively recruiting, the study (2017-004335-36) is expected to enroll approximately 120 Parkinson’s patients ages 50 or older with a dementia diagnosis. It is being conducted across several clinical sites in Spain,…

Continue Reading

News

UAB Researchers Awarded $2.5M to Study Role of Gut Microbiome in Parkinson’s

The U.S. Army Medical Research and Materiel Command has awarded a four-year, $2.5 million grant to a team of scientists at the University of Alabama at Birmingham (UAB) to investigate the role of the gut microbiome — the trillions of microorganisms and their genetic material that live in the intestinal tract — in Parkinson’s disease. A goal is to determine if…

Continue Reading

News

Investigational Herbal Therapy DA-9805 Shows Neuroprotective Effects in Parkinson’s Mouse Model

An investigational herbal product called DA-9805 exerts its neuroprotective activity by preventing mitochondria damage in brain cells, a mouse study has found. This compound is currently being evaluated in a Phase 2a clinical trial (NCT03189563) in early Parkinson’s disease patients. The study, “Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson’s disease,”…

Continue Reading